Cholesterol-lowering statins are commonly used to help prevent heart disease. Now a new study hints that they could shield women's hearts from the harms of certain breast cancer drugs.
The study focused on women in Canada who'd been treated with either chemotherapy drugs called anthracyclines or the medication Herceptin. Though the treatments can be lifesaving, they can also damage th...
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer.
Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs plummeted 18% between 2013 and 2016, after jumping 7.5% between 1986 and 2013. The figures apply to white Americans, the group that accounts for nearly all cases of melanoma in th...
Many people don't realize that cancer patients are in constant need of blood supplies.
Chemotherapy and radiation treatments for cancer can damage the body's ability to produce healthy blood cells and cause potentially life-threatening conditions. Blood transfusions help provide critical clotting factors, proteins and antibodies.
Chemotherapy can be hard on the heart, but an individualized exercise program may mitigate some of that damage, new research suggests.
Heart problems are a common side effect in patients with cancer because cancer treatments can impair heart function and structure or accelerate development of heart disease, especially when patients have risk factors such as high blood pressure, accor...
Early treatment with an immune-boosting therapy might improve the outlook of young children with an advanced form of cancer, a new small study suggests.
The trial involved 43 children with high-risk neuroblastoma, a cancer that starts in immature nerve cells. Researchers found that a new treatment approach -- involving an experimental antibody given right off the bat -- started to qui...
The treatments that childhood cancer patients receive often save their lives, but they also make survivors prone to heart troubles, a new study finds.
For the study, researchers examined heart disease rates in nearly 7,300 childhood cancer survivors (diagnosed at an average age of 7) and a "control group" of more than 36,000 people without cancer in the province of Ontario, Canada.
Could the DNA from a patient's breast tumor help doctors spot whether stray cancer cells are still in her blood?
That's what a small, new study suggests is possible. If the findings are replicated in a larger study, such a test might help determine whether a treatment is working or not. It also has the potential to reduce unnecessary additional treatments for breast cancer.
Glioblastoma brain cancer remains one of deadliest tumors, and new research shows five-year survival rates remain low for patients with the disease.
While there have been improvements in short- and medium-term survival rates for patients with the most common type of brain tumor in adults, only 6% of patients live for five years after diagnosis, according to the Mayo Clinic researc...
New research should reassure dads-to-be who've had testicular cancer that treatment with radiation or chemotherapy doesn't raise the risk of fathering babies with birth defects.
"Our research set out to investigate whether treatment for the most common cancer among young men leads to a higher risk of fathering a child with a birth defect and we saw no increased risk associated with ca...
Learning you have a cancer that looks imminently terminal is tough news to swallow.
And new research indicates that when given just one month to live, a significant number of patients still opt for aggressive and often costly interventions, despite little evidence to suggest they'll help.
A study of just over 100,000 patients in the United States found that the urge to under...
Scientists say they have used frozen testicular tissue to achieve the birth of a healthy baby monkey named Grady -- a success they hope to eventually translate to childhood cancer survivors whose treatment has left them infertile.
Infertility is a potential side effect of the chemotherapy and radiation used to treat various can...
It's one of the toughest cancers to beat. But new research suggests that identifying the genetics of pancreatic cancer in individual patients could boost survival for some.
The five-year survival rate for pancreatic cancer patients is less than 9 percent. One reason this cancer is so deadly is that many patients are diagnosed at a late stage and often with inoperable tumors.
Even when women have health insurance, high deductibles may delay them from having breast cancer diagnosed and treated, researchers say.
In a study of more than 3 million U.S. women with health insurance, the researchers found that those in plans with high deductibles waited several months more for a breast cancer diagnosis or treatment, versus women in low-deductible plans.
Deceased people who are cremated after having been treated with radioactive medications might be a health hazard to crematory operators, a new case study shows.
An Arizona crematorium became contaminated with radiation following the cremation of a man who received "radiopharmaceutical" treatment two days before he died, according to a research letter published Feb. 26 in the Journ...
The hair loss, fatigue and nausea were a given. As a nurse, Toni C. Wild had seen patients faced with these common side effects of chemotherapy. What Wild did not expect when she was diagnosed with breast cancer at age 29 is that the chemotherapy drugs she received would damage her heart.
"It certainly has been quite the journey," said Wild.
Many older breast cancer patients might worry that they will be struck by "chemo brain" after their treatments, but a new study suggests that only those who carry a gene linked to Alzheimer's face that risk.
Researchers found that breast cancer survivors carrying the APOE4 gene who underwent chemotherapy were more likely to experience long-term impairment in brain function.
People with curable cancers who try "complementary therapy" often refuse some part of standard care. And they may die as a result, researchers say.
U.S. cancer patients increasingly use complementary medicine -- a combination of standard care along with therapies that fall outside of mainstream medicine (such as acupuncture or massage). But little is known about the long-term results,...
Drugs designed to trigger a patient's immune system may help boost survival for those battling lung cancer, two new studies found.
The first study found that when the immunotherapy drug Keytruda (pembrolizumab) was combined with standard chemotherapy, the chance that a patient would die within the next 11 months plummeted by more than 50 percent, compared with being treated with chemo...
Young men who survive testicular cancer may need to worry about more than a return of their disease: A new study suggests they also face greater heart risks down the road.
"The overarching goal of our study is to implement early interventions in order to reduce the risk of heart disease," said researcher Dr. Mohammad Abu Zaid. An assistant professor of medicine at Indiana University's...
Two classes of blood pressure drugs show promise in preventing heart complications caused by chemotherapy for breast cancer, researchers report.
One in four women who receives the chemo drug Herceptin develops potentially dangerous heart problems. However, the drug is highly effective at treating an aggressive form of breast cancer called HER2-positive, the scientists added.